(i) The incidence rate of ADCs in the late ART era was 17 times higher in PLHIV than the general population (ii) Incidence rate of NADCs in late ART era remained twice higher in PLHIV versus general population
(i) More ADCs in PLHIV versus HIV negative (ii) More virus-related NADCs in PLHIV versus HIV negative (iii) More nonvirus-related NADCs in HIV negative versus PLHIV
(i) Overall incidence of ADCs was higher in PLHIV than the Italian general population (ii) Incidence of NADCs in PLHIV was similar to that of the Italian general population
Cumulative cancer incidence by age 65 and 75 years during 1996–2009 was higher in PLHIV versus HIV negative for all cancer types except colorectal, melanoma, and oropharynx
Key: ˄ = higher rate; ˅ = lower rate, ~ = similar rate, X = not part of the study. Mortality rate in the first year of ART. ADC mortality higher in pre-ART and lower post-ART while NADC lower in pre-ART and higher post-ART. ADCs: AIDS-defining cancers; NADCs: non-AIDS-defining cancers; HIV: human immunodeficiency virus; KS: Kaposi sarcoma; NHL: non-Hodgkin lymphoma; HL: Hodgkin lymphoma; ART: antiretroviral therapy; HAART: highly active antiretroviral therapy; PLHIV: people living with HIV.